Responses
Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
216 Tissue nanomechanical signature as a novel, clinically translatable predictor of response to immunotherapy combined with low-dose radiation
Compose a Response to This Article
Other responses
No responses have been published for this article.
